The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

Hospitals across the country have been cranking out news releases this week about patients who are among the first to receive a new MRI-safe pacemaker from Medtronic. But Medicare patients with the ...

WASHINGTON — Sometimes state-of-the-art medical technologies clash. More than 2 million Americans depend on pacemakers or defibrillators to keep their hearts beating right. But those lifesaving ...